Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome

Lam, Benjamin, Masellis, Mario, Freedman, Morris, Stuss, Donald T, Black, Sandra E·2013·Alzheimer's Research & Therapy

Cited by (386)

Items 201–300 of 386

  1. Atrophy trajectories in Alzheimer’s disease: how sex matters
    Anna Inguanzo, Konstantinos Poulakis, Javier Oltra, Silvia Maioli, Anna Marseglia, Daniel Ferreira, Rosaleena Mohanty, Eric Westman, Alzheimer’s Disease Neuroimaging Initiative · 2025 · Alzheimer s Research & Therapy
  2. Three-dimensional interactive network: Mitochondrial-metabolic-calcium homeostasis driving Alzheimer’s disease
    Tingting Liu, Zongting Rong, Jingwen Li, Haojie Wu, Jianshe Wei · 2025 · Genes & Diseases
  3. Cognitive Results of CANTAB Tests and Their Change Due to the First Dose of Donepezil May Predict Treatment Efficacy in Alzheimer Disease
    Jurgita Kuzmickienė, Gintaras Kaubrys · 2015 · Medical Science Monitor
  4. Heterogeneity and Factorial Structure in Alzheimer’s Disease: A Cognitive Perspective
    Andrea Zangrossi, Sonia Montemurro, Gianmarco Altoè, Sara Mondini · 2021 · Journal of Alzheimer s Disease
  5. Pathology steered stratification network for subtype identification in Alzheimer's disease
    Enze Xu, Jingwen Zhang, Jiadi Li, Qianqian Song, Defu Yang, Guorong Wu A, Minghan Chen · 2023 · Medical Physics
  6. Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau
    Andrew Arner, Edward M. Rockenstein, Michael Mante, Jazmin B. Florio, Deborah Masliah, Bahar Salehi, Anthony Adame, Cassia Overk, Eliezer Masliah, Robert A. Rissman · 2018 · Journal of Alzheimer s Disease
  7. Associations Between Depression, Traumatic Brain Injury, and Cognitively-Defined Late-Onset Alzheimer’s Disease Subgroups
    Julia Bauman, for the Executive Prominent AD (EPAD) investigators, Laura E. Gibbons, Mackenzie R. Moore, Shubhabrata Mukherjee, Susan M. McCurry, Wayne C. McCormick, James D. Bowen, Emily H. Trittschuh, M. Maria Glymour et al. · 2019 · Journal of Alzheimer s Disease
  8. Differential Gene Expression and DNA Methylation in the Risk of Depression in LOAD Patients
    Suraj Upadhya, Daniel Oliveros Gingerich, Michael William Lutz, Ornit Chiba‐Falek · 2022 · Biomolecules
  9. Identifying a subtype of Alzheimer’s disease characterised by predominant right focal cortical atrophy
    Ko Woon Kim, Seongbeom Park, Hyunjin Jo, Soo Hyun Cho, Seung Joo Kim, Yeshin Kim, Hyemin Jang, Duk Lyul Na, Sang Won Seo, Hee Jin Kim · 2020 · Scientific Reports
  10. Characterizing Differences in Functional Connectivity Between Posterior Cortical Atrophy and Semantic Dementia by Seed-Based Approach
    Yi Chen, Qingze Zeng, Yunyun Wang, Xiao Luo, Yan Sun, Lumi Zhang, Xiaoyan Liu, Kaicheng Li, Minming Zhang, Guoping Peng · 2022 · Frontiers in Aging Neuroscience
  11. Does the Right Focal Variant of Alzheimer’s Disease Really Exist? A Literature Analysis
    Carlo Abbate, Pietro Davide Trimarchi, Silvia Inglese, Sarah Damanti, Giulia A.M. Dolci, Simona Ciccone, Paolo Dionigi Rossi, Daniela Mari, Beatrice Arosio, Renzo Bagarolo et al. · 2019 · Journal of Alzheimer s Disease
  12. Analysis of Spatial Working Memory Using the Y-Maze on Rodents Treated with High-Calorie Diet and Moderate-Intensity Exercise
    Rezy Ramawan Melbiarta, Viskasari Pintoko Kalanjati, Lilik Herawati, Yusuf Salim, Zulhabri Othman · 2022 · Folia Medica Indonesiana
  13. Disentangling sex-dependent effects of APOE on diverse trajectories of cognitive decline in Alzheimer's disease
    Haixu Ma, Zhuoyu Shi, Minjeong Kim, Bin Liu, Patrick J. Smith, Yufeng Liu, Guorong Wu A · 2024 · NeuroImage
  14. Disentangling brain atrophy heterogeneity in Alzheimer's disease: A deep self-supervised approach with interpretable latent space
    Sohyun Kang, Sung-Woo Kim, Joon‐Kyung Seong · 2024 · NeuroImage
  15. The Association between Polygenic Hazard and Markers of Alzheimer’s Disease Following Stratification for APOE Genotype
    Matteo De Marco, Riccardo Manca, Janine Kirby, Guillaume M. Hautbergue, Daniel J. Blackburn, Stephen B. Wharton, Annalena Venneri, Alzheimer’s Disease Neuroimaging Initiative · 2020 · Current Alzheimer Research
  16. Analysis of gene expression profiles in Alzheimer’s disease patients with different lifespan: A bioinformatics study focusing on the disease heterogeneity
    Ji Zhang, Xiaojia Li, Jun Feng Xiao, Yang Xiang, Fang Ye · 2023 · Frontiers in Aging Neuroscience
  17. Heterogeneity in subjective cognitive decline in the Sino Longitudinal Study on Cognitive Decline(SILCODE): Empirically derived subtypes, structural and functional verification
    Zhenrong Fu, Mingyan Zhao, Yuxia Li, Yirong He, Xuetong Wang, Zongkui Zhou, Ying Han, Shuyu Li · 2023 · CNS Neuroscience & Therapeutics
  18. Current evidence for J147 as a potential therapeutic agent in nervous system disease: a narrative review
    Fang Qiu, Yanmei Wang, Yunbo Du, Changchun Zeng, Yuqiang Liu, Haobo Pan, Changneng Ke · 2023 · BMC Neurology
  19. Heterogeneous effects of genetic risk for Alzheimer’s disease on the phenome
    Hei Man Wu, Alison Goate, Paul F. O’Reilly · 2021 · Translational Psychiatry
  20. Apolipoprotein E ε-4 as a genetic determinant of Alzheimer’s disease heterogeneity
    Maritha J. Kotze, Theresa Brand, Jakobus Pretorius, Susan J. van Rensburg, Hilmar Klaus Luckhoff · 2015 · Degenerative Neurological and Neuromuscular Disease
  21. A similarity-based approach to leverage multi-cohort medical data on the diagnosis and prognosis of Alzheimer's disease
    Hongjiu Zhang, Fan Zhu, Hiroko Hayama Dodge, Gerald A. Higgins, Gilbert S. Omenn, Yuanfang Guan, the Alzheimer's Disease Neuroimaging Initiative · 2018 · GigaScience
  22. AmpliSeq Transcriptome of Laser Captured Neurons from Alzheimer Brain: Comparison of Single Cell Versus Neuron Pools
    Wenjun Deng, Changhong Xing, Rob David, Diego Mastroeni, MingMing Ning, Eng H. Lo, Paul D. Coleman · 2019 · Aging and Disease
  23. The Two-Step Strategy Could Be Inadequate and Counteracting to Diagnose Prodromal Dementia or Mild Cognitive Impairment
    Carlo Abbate, Pietro Davide Trimarchi, Silvia Inglese, Alessia Gallucci, Emanuele Tomasini, Renzo Bagarolo, Fabrizio Giunco · 2020 · Frontiers in Aging Neuroscience
  24. A Multiform Heterogeneity Framework for Alzheimer’s Disease Based on Multimodal Neuroimaging
    Kun Zhao, Pindong Chen, Dong Wang, Rongshen Zhou, Guolin Ma, Yong Liu · 2024 · Biological Psychiatry
  25. Longitudinal trajectories of cognitive reserve in hypometabolic subtypes of Alzheimer's disease
    Fedor Levin, Michel J. Grothe, Martin Dyrba, Nicolai Franzmeier, Stefan Johannes Teipel · 2023 · Neurobiology of Aging
  26. Identifying novel associations in GWAS by hierarchical Bayesian latent variable detection of differentially misclassified phenotypes
    Afrah Shafquat, Ronald G. Crystal, Jason G. Mezey · 2020 · BMC Bioinformatics
  27. Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective
    Sepideh Shokouhi, Desmond L. Campbell, Aaron B. Brill, Harry E. Gwirtsman, The Alzheimer's Disease Neuroimaging Initiative · 2016 · Brain Pathology
  28. Brain microstructure abnormalities in the 3xTg-AD mouse – A diffusion MRI and morphology correlation study
    Falangola, Maria Fatima, Nie, Xingju, Voltin, Joshua, Ward, Ralph, Dhiman, Siddhartha, Nietert, Paul J., Jensen, Jens H. · 2022 · Magnetic Resonance Imaging
  29. Spatio-temporal dynamic functional brain network for mild cognitive impairment analysis
    Shipeng Wen, Jingru Wang, Wenjie Liu, Xianglian Meng, Zhuqing Jiao · 2025 · Frontiers in Neuroscience
  30. Brain and retina in Alzheimer's disease: Pathological intersections and estimates from imaging
    M. Amin Banihashemi, Saffire Hanna Krance, Patrick Xiang Ji, Morgan Koo, Julie Ottoy, Richard H. Swartz, Peter J. Kertes, Christopher Hudson, Maged Goubran, Sandra E. Black · 2025 · Alzheimer s & Dementia
  31. Integrative epigenomic landscape of Alzheimer’s Disease brains reveals oligodendrocyte molecular perturbations associated with tau
    Oatman, Stephanie R., Reddy, Joseph S., Atashgaran, Amin, Wang, Xue, Min, Yuhao, Quicksall, Zachary, Vanelderen, Floor, Carrasquillo, Minerva M., Liu, Chia-Chen, Yamazaki, Yu et al. · 2026 · Nature Communications
  32. Evolving prion-like tau conformers differentially alter postsynaptic proteins in neurons inoculated with distinct isolates of Alzheimer’s disease tau
    Lenka Hromádková, Chae Kim, Tracy Haldiman, Li‐Hua Peng, Xiongwei Zhu, Mark L. Cohen, Rohan de Silva, Jiri Safar · 2023 · Cell & Bioscience
  33. Receptor-based approaches and therapeutic targets in Alzheimer’s disease along with role of AI in drug designing: Unraveling pathologies and advancing treatment strategies
    Mohsina Patwekar, Faheem Patwekar, Daniyal Shaikh, Shaikh Rohin Fatema, Sunil J. Aher, Rohit Sharma · 2023 · Applied Chemical Engineering
  34. Clinical predictors of Alzheimer's disease‐like brain atrophy in individuals with memory complaints
    Ahmet Alp Karakaşlı, Esra Ozkan, Melike Karaçam Doğan, Duygu Çap, Ayca Akgoz Karaosmanoglu, Sevilay Karahan, Nabi Zorlu, Esen Saka, Yavuz Ayhan · 2024 · Brain and Behavior
  35. Examining heterogeneity in dementia using data-driven unsupervised clustering of cognitive profiles
    Sayantan Kumar, Inez Y. Oh, Suzanne E. Schindler, Nupur Ghoshal, Zachary B. Abrams, Philip Payne · 2024 · PLoS ONE
  36. The interaction of insoluble Amyloid‐β with soluble Amyloid‐β dimers decreases Amyloid‐β plaque numbers
    Else F. van Gerresheim, Arne Herring, Lothar Gremer, Andreas Müller‐Schiffmann, Kathy Keyvani, Carsten Korth · 2020 · Neuropathology and Applied Neurobiology
  37. A new data analysis approach for measuring longitudinal changes of metabolism in cognitively normal elderly adults
    Sepideh Shokouhi, William R. Riddle, Hakmook Kang · 2017 · Clinical Interventions in Aging
  38. Subtypes of functional brain connectivity as early markers of neurodegeneration in Alzheimer’s disease
    Pierre Orban, Angela Tam, Sebastian Georg Wenzel Urchs, Mélissa Savard, Cécile Madjar, AmanPreet Badhwar, Christian L. Dansereau, Jacob W. Vogel, Amir Schmuel, Alain Dagher et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Structural similarity networks reveal brain vulnerability in dementia
    M. Montagnese, A. Ebneabbasi, N. García-San-Martín, Clara Pecci-Terroba, R. Romero-Garcia, S. Morgan, J. Cole, J. Seidlitz, T. Rittman, R. Bethlehem · 2025 · Alzheimer's & Dementia
  40. Pathway enrichment in genome‐wide analysis of longitudinal Alzheimer's disease biomarker endophenotypes
    Thea Jacobson Rosewood, Kwangsik T. Nho, Shannon L. Risacher, Shiwei Liu, Sujuan Gao, Li Shen, Tatiana Foroud, Andrew J. Saykin, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Alzheimer s & Dementia
  41. Hippocampal Subfield Volume in Relation to Cerebrospinal Fluid Amyloid‐ß in Early Alzheimer's Disease: Diagnostic Utility of 7T MRI
    Oluwatobi F Adeyemi, Penny Anne Gowland, Richard W Bowtell, Olivier E. Mougin, Akram A. Hosseini · 2025 · European Journal of Neurology
  42. Immunological characterization and diagnostic models of RNA N6-methyladenosine regulators in Alzheimer's disease
    Yuan Hui, Qi Ma, Xue-Rui Zhou, Huan Wang, Jianhua Dong, Lina Gao, Tian Zhang, Yanyi Li, Ting Gong · 2023 · Scientific Reports
  43. Comparative mapping of single‐cell transcriptomic landscapes in neurodegenerative diseases
    Elliot Keats Shwab, Zhaohui Man, Daniel C. Gingerich, Julia Gamache, Melanie E. Garrett, Geidy E. Serrano, Thomas G. Beach, Gregory E. Crawford, Allison E. Ashley‐Koch, Ornit Chiba‐Falek · 2025 · Alzheimer s & Dementia
  44. Stem Cell Technology for (Epi)genetic Brain Disorders
    Renzo J. M. Riemens, Edilene Siqueira Soares, Manel Esteller, Raúl Delgado‐Morales · 2017 · Advances in experimental medicine and biology
  45. Study on synthesis and properties of nanoparticles loaded with amaryllidaceous alkaloids
    Lihong Duan, Meng Li, Chunbao Wang, Qingmei Wang, Quanquan Liu, Wanfeng Shang, Yajing Shen, Zhuohua Lin, Tongyang Sun, Daping Quan et al. · 2017 · Open Life Sciences
  46. Az Alzheimer-kór heterogenitása
    Nóra Balázs, Tibor Kovács · 2021 · Orvosi Hetilap
  47. The Effects of Amyloid-β on Metabolomic Profiles of Cardiomyocytes and Coronary Endothelial Cells
    Sehwan Jang, Nataliya Chorna, Keishla M. Rodríguez‐Graciani, Mikhail Y. Inyushin, Silvia Fossati, Sabzali A. Javadov · 2023 · Journal of Alzheimer s Disease
  48. Spontaneous confabulations in amnestic-mild cognitive impairment due to Alzheimer’s disease: a new (yet old) atypical variant?
    Carlo Abbate, Pietro Davide Trimarchi, Emanuela Rotondo, Silvia Inglese, Paola Nicolini, Paolo Dionigi Rossi, Beatrice Arosio, Daniela Mari · 2016 · Neurocase
  49. A case of right Alzheimer’s disease
    Carlo Abbate, Pietro Davide Trimarchi, Silvia Inglese, Sarah Damanti, Giulia A. M. Dolci, Simona Ciccone, Paolo Dionigi Rossi, Daniela Mari, Beatrice Arosio, Matteo Cesari · 2019 · Aging Clinical and Experimental Research
  50. Coh-Metrix-Dementia: análise automática de distúrbios de linguagem nas demências utilizando Processamento de Línguas Naturais
    Andre Luiz Verucci da Cunha · 2016
  51. Heterogeneous Treatment Effect Estimation using machine learning for Healthcare application: tutorial and benchmark
    Yaobin Ling, Pulakesh Upadhyaya, Luyao Chen, Xiaoqian Jiang, Yejin Kim · 2021 · arXiv (Cornell University)
  52. Self-Organized Prediction-Classification- Superposition of Longitudinal Cognitive Decline in Alzheimer's Disease: An Application to Novel Clinical Research Methodology
    Hiroyuki Sato, Ryoichi Hanazawa, Keisuke Suzuki, Atsushi Hashizume, Akihiro Hirakawa · 2025 · IEEE Journal of Biomedical and Health Informatics
  53. A Novel Dynamic Neural Network for Heterogeneity-Aware Structural Brain Network Exploration and Alzheimer’s Disease Diagnosis
    Wenju Cui, Yilin Leng, Yunsong Peng, Chen Bai, Lei Li, Xi Jiang, Gang Yuan, Jian Zheng · 2025 · IEEE Transactions on Neural Networks and Learning Systems
  54. Mating and Memory: An Educational Primer for Use with “Epigenetic Control of Learning and Memory in Drosophila by Tip60 HAT Action”
    Rebecca L. Schmidt, Sara L. Sheeley · 2015 · Genetics
  55. Preliminary validation of the apraxia battery for adults-second edition (ABA-2) in Greek patients with dementia
    Georgios Papadopoulos, Dimitrios Parissis, Eleni Konstantinopoulou, Konstantinos S. Natsis, Anna Gotzamani‐Psarrakou, Panagiotis Ioannidis · 2021 · Acta Neurologica Belgica
  56. Distribution of Cortical Atrophy Associated with Cognitive Decline in Alzheimer’s Disease: A Cross-Sectional Quantitative Structural MRI Study from PUMCH Dementia Cohort
    Chenhui Mao, Bo Hou, Jie Li, Shanshan Chu, Xinying Huang, Jie Wang, Liling Dong, Caiyan Liu, Feng Feng, Bin Peng et al. · 2022 · Current Alzheimer Research
  57. Translating clinical notes into quantitative measures—a real-world observation on the response to cholinesterase inhibitors or selective serotonin reuptake inhibitors prescribed to outpatients with dementia using electronic medical records
    Jill S. Chotiyanonta, Kengo Onda, Milap A. Nowrangi, Xin Li, Xin Xu, Roy Adams, Constantine George Lyketsos, Peter P. Zandi, Kenichi Oishi · 2023 · Frontiers in Pharmacology
  58. Benefits of a 12-Week Non-Drug “Brain Fitness Program” for Patients with Attention-Deficit/Hyperactive Disorder, Post-Concussion Syndrome, or Memory Loss
    Majid Fotuhi, Noah D. Khorrami, Cyrus A. Raji · 2023 · Journal of Alzheimer s Disease Reports
  59. Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status
    Jacopo Di Napoli, Andrea Arighi, Giorgio Conte, Tiziana Carandini, Luca Sacchi, Marina Arcaro, Chiara Fenoglio, Federica Sorrentino, Matteo Mercurio, Anna Margherita Pietroboni et al. · 2023 · European Journal of Neurology
  60. Exploring exosomes to provide evidence for the treatment and prediction of Alzheimer’s disease
    XIANGYU QUAN, XUETING MA, GUODONG LI, XUEQI FU, JIANGTAO LI, LINLIN ZENG · 2023 · Biocell
  61. Case report: Rapidly progressive neurocognitive disorder with a fatal outcome in a patient with PU.1 mutated agammaglobulinemia
    Rada Mišković, Jelena Ljubičić, Branka Bonaci Nikolic, Ana Petković, Vladana Marković, Ivan Ranković, Jelena Djordjevic, Ana Stankovic, Kristel Klaassen, Sonja Pavlović et al. · 2024 · Frontiers in Immunology
  62. Longitudinal Relationship Between Brain Atrophy Patterns, Cognitive Decline, and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease Explored by Orthonormal Projective Non-Negative Matrix Factorization
    Lan Shui, Dean K. Shibata, Kwun Chuen Gary Chan, Wenbo Zhang, Junhyoun Sung, David R. Haynor, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Journal of Alzheimer s Disease
  63. Prediction of Cognitive Decline for Enrichment of Alzheimer's Disease Clinical Trials
    Angela Tam, César Laurent, Serge G. Gauthier, Christian L. Dansereau · 2022 · The Journal of Prevention of Alzheimer s Disease
  64. Biomarkers of Alzheimer’s Disease
    Usman Saeed, Walter Swardfager, Sandra E. Black, Mario Masellis · 2017 · Mental health and illness worldwide
  65. Neuroimaging Markers for Determining Former American Football Players at Risk for Alzheimer's Disease
    Vijaykumar M. Baragi, Ramtilak Gattu, Gabriela Trifan, John L. Woodard, Kortney Meyers, Tim S. Halstead, Eric Hipple, Ewart Mark Haacke, Randall R. Benson · 2022 · Neurotrauma Reports
  66. Research on Alzheimer's syndromes is critical to improve diagnosis, patient management and non-pharmacological treatments, but is under-pursued
    Carlo Abbate · 2022 · Frontiers in Aging Neuroscience
  67. Protective effects of salicylate on PKA inhibitor (H-89)-induced spatial memory deficit via lessening autophagy and apoptosis in rats
    Leila Azimi, Maryam Kachooeian, Fariba Khodagholi, Asal Yans, Soomaayeh Heysieattalab, Gelareh Vakilzadeh, Nasim Vosoughi, Mehdi Sanati, Ghorban Taghizadeh, Mohammad Sharif Sharifzadeh · 2016 · Pharmacology Biochemistry and Behavior
  68. Topographic Markers Drive Proteinopathies to Selection of Target Brain Areas at Onset in Neurodegenerative Dementias
    Carlo Abbate · 2018 · Frontiers in Aging Neuroscience
  69. Biomarker Modelling of Early Molecular Changes in Alzheimer’s Disease
    Ross W. Paterson, Jamie Toombs, Catherine F. Slattery, Jonathan M. Schott, Henrik Zetterberg · 2013 · Molecular Diagnosis & Therapy
  70. A Knowledge-based Integrative Modeling Approach for In-Silico Identification of Mechanistic Targets in Neurodegeneration with Focus on Alzheimer's Disease
    Erfan Younesi · 2014
  71. Revealing Individual Neuroanatomical Heterogeneity in Alzheimer’s Disease
    Serena Verdi, Seyed Mostafa Kia, Keir X. X. Yong, Duygu Tosun, Jonathan M. Schott, André F. Marquand, James Howard Cole, the Alzheimer’s Disease Neuroimaging Initiative · 2022 · medRxiv
  72. Neuroimaging Compendium of Microglia, Amyloid, Tau, and Neurodegeneration Across Clinical Variants of Alzheimer Disease
    Hannah M. Houlihan, Diana Guzman, Anna P. Smith, Thairi Sanchez, Aubrey S. Johnson, William Charles Kreisl, Stephanie Cosentino, James McC. Noble, Patrick J. Lao · 2025 · Alzheimer Disease & Associated Disorders
  73. Brain tau PET-based identification and characterization of subpopulations in patients with Alzheimer’s disease using deep learning-derived saliency maps
    Yanxiao Li, Xiuying Wang, Qi Ge, Manuel B. Graeber, Shaozhen Yan, Jian Li, Shuyu Li, Wenjian Gu, Shuo Hu, Tammie L.S. Benzinger et al. · 2025 · EJNMMI Physics
  74. Different Cognitive Profiles Are Associated with Progression Rate and Age at Death in Probable Alzheimer’s Disease
    Ajay Sood, Valory Pavlik, Eveleen J. Darby, Wenyaw Chan, Rachelle Smith Doody · 2021 · Journal of Alzheimer s Disease
  75. Two Routes to Alzheimer’s Disease Based on Differential Structural Changes in Key Brain Regions
    Yasmin Hollenbenders, Alzheimer’s Disease Neuroimaging Initiative, Monika Pobiruchin, Alexandra Reichenbach · 2023 · Journal of Alzheimer s Disease
  76. Distinct Heterocyclic Moieties Govern the Selectivity of Thiophene‐Vinylene‐Based Ligands towards Aβ or Tau Pathology in Alzheimer's Disease
    Linnea Björk, Hamid Shirani, Yogesh Todarwal, Mathieu Linares, Rubén Vidal, Bernardino Francesco Ghetti, Patrick Norman, Therése Klingstedt, K. Peter R. Nilsson · 2023 · European Journal of Organic Chemistry
  77. Genome-Wide Association Analysis across Endophenotypes in Alzheimer’s Disease: Main Effects and Disease Stage-Specific Interactions
    Thea Jacobson Rosewood, Kwangsik T. Nho, Shannon L. Risacher, Sujuan Gao, Li Shen, Tatiana Foroud, Andrew J. Saykin, on behalf of the Alzheimer’s Disease Neuroimaging Initiative · 2023 · Genes
  78. Association of RDoC dimensions with post mortem brain transcriptional profiles in Alzheimer's disease
    Weiqian Jiang, Jonathan S. Vogelgsang, Shu Dan, Peter T. Durning, Thomas H. McCoy, Sabina Berretta, Torsten Klengel · 2025 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  79. Identifying sex-specific sub-phenotypes of Alzheimer's disease progression using longitudinal electronic health records
    Weimin Meng, Qiang Yang, Jie Xu, Yu Huang, Cankun Wang, Qianqian Song, Lixin Song, Jiang Bian, Qin Ma, Anjun Ma et al. · 2026 · EBioMedicine
  80. Structural Correlates of Depressive Symptoms in Prodromal Alzheimer’s Disease
    Javier Olazarán, Pablo García‐Polo, Daniel Garcia–Frank, Alicia Quirós, Juan Antonio Hernandez-Tamames, Carmen Acedo, Juan Álvarez‐Linera, Ana Frank · 2016 · Journal of Advances in Medicine and Medical Research
  81. Diencephalic versus Hippocampal Amnesia in Alzheimer’s Disease: The Possible Confabulation-Misidentification Phenotype
    Carlo Abbate, Pietro Davide Trimarchi, Giorgio Fumagalli, Alessia Gallucci, Emanuele Tomasini, Stefania Fracchia, Isabella Rebecchi, Elisabetta Morello, Anna Fontanella, Paola Maria Rita Parisi et al. · 2022 · Journal of Alzheimer s Disease
  82. Multi-modal Latent Factor Exploration of Atrophy, Cognitive and Tau Heterogeneity in Alzheimer’s Disease
    Nanbo Sun, Elizabeth C. Mormino, Jianzhong Chen, Mert Rory Sabuncu, B.T. Thomas Yeo, Alzheimer’s Disease Neuroimaging Initiative · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  83. Prediction, prognosis and monitoring of neurodegeneration at biobank-scale via machine learning and imaging
    A. Dadu, M. Ta, N. Tustison, Ali Daneshmand, Ken Marek, Andrew B. Singleton, R. H. Campbell, M. Nalls, H. Iwaki, B. Avants et al. · 2024 · medRxiv
  84. The influence of sample size and covariate distributions on neuroanatomical normative modeling
    Camille Elleaume, Bruno Hebling Vieira, Dorothea L. Floris, Nicolas Langer, the Australian Imaging Biomarkers and Lifestyle flagship study of ageing · 2025 · eLife
  85. Suroy-Suroy: An Immersive Virtual Reality Therapy Game for Persons Living with Dementia in the Philippines
    Veeda Michelle M. Anlacan, Angelo Cedric F. Panganiban, Roland Dominic G. Jamora, Isabel Teresa O. Salido, Romuel Aloizeus Z. Apuya, Bryan Andrei C. Galecio, Michael Lucas Tee, Maria Eliza R. Aguila, Cherica Tee, Jaime D. L. Caro · 2024 · Communications in computer and information science
  86. Post-Hoc Assessment of Cognitive Efficacy in Alzheimer’s Disease Using a Latent Growth Mixture Model in AMBAR, a Phase 2B Randomized Controlled Trial
    Nicolai D. Ayasse, Walter F. Stewart, Richard B. Lipton, David Gómez‐Ulloa, M. Chris Runken · 2024 · Current Alzheimer Research
  87. Gray matter structural and molecular signatures in Alzheimer's disease and late-life depression
    Shuo Yang, Xuemei Wang, Yan Yan, Jianbo Zhang, Yuyue Wei, Dai Zhang, Wenjun Yao · 2025 · Journal of Affective Disorders
  88. Spontaneous isomerization of tau is most prevalent in Alzheimer’s disease
    Evan E. Hubbard, Kevin Reagle, Matthew K. Lui, Maxence Derbez-Morin, Gennifer E. Merrihew, Michael J. MacCoss, Ryan R. Julian · 2026 · NeuroMarkers.
  89. A neuroimaging biomarker for disease staging in clinically diagnosed Alzheimer’s disease
    Zhuangzhuang Li, S Q Yan, Kun Zhao, Dawei Wang, Hongxiang Yao, Bo Zhou, Zhifa Zhang, Pan Wang, Zhengluan Liao, Yan Chen et al. · 2026 · BMC Medicine
  90. Proteomics reveals three molecular subtypes of Alzheimer's disease with distinct progression patterns
    Xiao‐He Hou, Wen Zhang, Kairan Kang, Yifei Jin, Peng Ren, Linbo Wang, Zeyu Li, Yuzhu Li, Jia You, Bei Zhang et al. · 2026 · Alzheimer s & Dementia
  91. A pilot protocol to assess the feasibility of a virtual multiple crossover, randomized controlled trial design using methylphenidate in mild cognitive impairment
    Libby A. DesRuisseaux, Victoria J. Williams, Alison J. McManus, Anoopum S. Gupta, Becky Catherine Carlyle, Hamed Azami, Jessica A. Gerber, Anna M. Bolling, Carolyn L. Cook, Rebecca A. Betensky et al. · 2020 · Trials
  92. Domain-specific cognitive impairment is differentially affected by Alzheimer disease tau pathologic burden and spread
    Stephanie Doering, Nicole S. Mckay, Nayid Jana, Kaitlyn Dombrowski, Austin A. McCullough, Peter R. Millar, Diana Hobbs, Rohan Agrawal, S. Flores, J. Llibre-Guerra et al. · 2024 · Imaging Neuroscience
  93. THIDS: Triplet High-Order Individual Differential Structural Brain Network
    Dailin Wen, Chunzhi Zhao, Tülay Adalı, Daoqiang Zhang, Vince D. Calhoun, Shile Qi · 2025 · IEEE International Symposium on Biomedical Imaging (ISBI)
  94. APLICABILIDADE DE UMA BATERIA NEUROPSICOLÓGICA EM IDOSOS COM COMPROMETIMENTO COGNITIVO LEVE E DOENÇA DE ALZHEIMER
    Mariana Bonotto Mallmann, Marlene Doring · 2018 · Saúde e Pesquisa
  95. Parting with the Concept of Alzheimer’s Disease in Senium
    Pavel Kalvach, Martin Vogner · 2019 · OBM Geriatrics
  96. Individual differences in cognitive neuropsychology
    Donald T. Stuss · 2017 · Personality and Individual Differences
  97. Possible clinical anatomical features of right Alzheimer’s disease (RAD)
    C. Abbate, P. Trimarchi, Silvia Inglese, E. Tomasini, A. Gallucci, S. Damanti, S. Ciccone, P. Rossi, D. Mari, B. Arosio et al. · 2020 · Aging Clinical and Experimental Research
  98. Examining real-world Alzheimer’s disease heterogeneity using neuroanatomical normative modelling
    Flavia Loreto, Serena Verdi, Seyed Mostafa Kia, Aleksandar Duvnjak, Haneen Hakeem, Anna Fitzgerald, Neva Patel, Johan Lilja, Zarni Win, Richard J. Perry et al. · 2022 · medRxiv
  99. Tau accumulates differently in four subtypes of Alzheimer's disease
    Takahito Yoshizaki, Shinobu Minatani, Hiroto Namba, Akitoshi Takeda, Joji Kawabe, Hideko Mizuta, Yasuhiro Wada, Aya Mawatari, Yasuyoshi Watanabe, Hitoshi Shimada et al. · 2023 · Neurology and Clinical Neuroscience
  100. New Alzheimer's association workgroup criteria underestimate syndromes in Alzheimer's disease definition
    Carlo Abbate, Alessia Gallucci · 2025 · Journal of Alzheimer s Disease